Continue your journey online

Advanced manufacturing technologies, such as 3-dimensional printing (3DP), for pharmaceutical dosage form development and manufacturing are gaining increasing attention and interest from the pharmaceutical industry, academia, governments, and regulatory authorities around the world. This is based on the po...

What makes EZfill Smart truly “smart”? This session explores how innovations in primary packaging and Ready-to-Use (RTU) processing can transform drug product manufacturing. We'll compare bulk versus RTU approaches and highlight how format selection directly impacts efficiency, safety, and quality. Featu...

This session will address the evolving CMC strategies required as the ADC landscape advances toward more potent and precise therapies. As manufacturers face the challenge of keeping pace with these developments, the discussion will explore practical strategies for streamlining manufacturing processes while...

This session will address the critical challenges facing today's high-pressure pharmaceutical development landscape, where every decision carries significant weight for companies ranging from emerging biotechs navigating investment challenges on their path to IND, to established biopharma organizations sca...

Welcome to this special on-site episode of our podcast, recorded live at CPHI Frankfurt 2025, the premier global event for the pharmaceutical industry. In this episode, Editor Vivian Xie speaks to Sabine Kapasi, global health strategist, entrepreneur, and CEO of Enira Consulting. This year’s gathering brou...

As demand for adherent cell culture expands across Cell and Gene Therapies (CGT) and Advanced Therapy Medicinal Products (ATMPs), sustainable and scalable solutions are critical to meeting future manufacturing needs. This session will explore how innovative bioprocessing approaches can reduce environmental...

The biotech industry is undergoing rapid transformation – driven by technological innovation, global market shifts, and mounting healthcare cost pressures. As a result, the need for cost-efficient, scalable, and reliable biologics manufacturing has never been more critical.
Enzene’s response to this...

The Biopharmaceutics Classification System (BCS) enables the scientific and regulatory framework for granting biowaivers of in vivo bioequivalence studies. By categorizing drug substances according to solubility and permeability, the BCS allows the substitution of traditional clinical trials with validated...

The Aidaptus autoinjector and Alba® & Nexa® syringes are advanced, flexible platforms designed to meet the increasing demand for subcutaneous delivery of high value injectables. Autoinjector-syringe compatibility is critical to the success of the combination product. To ensure reliable and scalable produ...

In the complex and highly regulated pharmaceutical and healthcare sectors, the ability to anticipate, withstand, respond to, and recover from disruptions is critical. This webinar will explore the fundamentals and strategic value of Business Continuity Management (BCM), with a particular focus on its align...

This session presents primary data from the ENCACTUS clinical trial, an independent, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Nerviplex, a nucleotide-based formulation, in the treatment of carpal tunnel syndrome. Emphasis will be placed on clinical endpoints,...

Pharmaceutical manufacturing is undergoing a profound transformation. Geopolitical volatility, rising demand for specialized therapies, inflationary pressures, and shifting regulatory expectations are reshaping how and where medicines are made. In this keynote, we’ll explore the evolving market dynamics th...

In an industry where drug development often spans over a decade, accelerating timelines is critical to both reduce costs and improve patient access to life-saving therapies. This session explores strategies to streamline the development phase without compromising on safety or quality. Participants will gai...

Green chemistry and low-carbon technologies, including continuous flow chemistry and biocatalysis, contribute significantly to sustainable pharmaceutical manufacturing. PharmaBlock's innovative approaches in this field, recognized by the 2023 and 2024 ACS CMO Excellence in Green Chemistry Awards, demonstra...

As pharmaceutical companies push toward bold sustainability goals, transforming manufacturing processes for generic drugs is becoming a vital focus. While advancements in energy efficiency, packaging reduction, and logistics play a role, the most meaningful environmental impact may be found further upstrea...

During the interview Gust Desmedt, President Pharma Global of Brenntag shared his thoughts about: • This year’s Brenntag Pharma motto for CPHI “More than you think” • Brenntag’s main value proposition to pharmaceutical and biopharma customers • How Brenntag uses CPHI to showcase this approach • And...

This presentation examines evolving therapeutic antibody processes. Processing of conventional mAbs continues to mature, while new chromatography approaches are required for multispecifics and fragments—as a one-size-fits-all strategy has become outdated. Optimizing capture requires selecting processes bas...

This session will present a compelling real-world success story demonstrating how technology can provide CDMOs with a decisive competitive advantage in a market where efficiency and quality are paramount. The presentation will showcase how implementing Artificial Intelligence transformed a pharmaceutical m...

Innovative approaches to medicine distribution frequently fall short of reaching the people who need them the most, particularly in developing nations where acceptance is slowed by legislative, financial, and infrastructure constraints. Using India as a manufacturing powerhouse and a case study in unmet a...

At Actylis, we understand that complexity can slow innovation and strain resources. We will explore how our comprehensive approach helps customers simplify and streamline their pre-production workflows so they can focus their energy where it counts: on manufacturing. From procurement through to the finish...

In today’s rapidly evolving global landscape, the (bio-)pharmaceutical industry faces increasing complexity, from shifting market dynamics to rising sustainability expectations. The keynote explores how long-term, trust-based relationships between Contract Development and Manufacturing Organizations (CDMOs...

SCHOTT Pharma proudly introduces a new polymer container for the evolving demands of biologic therapies to its trusted SCHOTT TOPPAC® family. The SCHOTT TOPPAC® cartridge platform, made from advanced Cyclic Olefin Copolymer (COC), delivers outstanding drug stability and safety. Its inert surface, low extra...

This presentation examines evolving therapeutic antibody processes. Processing of conventional mAbs continues to mature, while new chromatography approaches are required for multispecifics and fragments—as a one-size-fits-all strategy has become outdated. Optimizing capture requires selecting processes bas...

In this session, presenters will discuss challenges and explore potential solutions associated with establishing robust and resilient vaccine manufacturing and supply chains in low- and middle-income countries (LMICs). While these regions face significant constraints in manufacturing capabilities and suppl...

Discover a novel computational method for analyzing break-loose and extrusion force (BLEF) data. By moving beyond traditional assumptions, this approach unlocks deeper insights into injection dynamics—improving accuracy in predicting injector performance and informing better design decisions.

PFAS are a large family of synthetic chemicals highly resistant to heat, water, and chemical breakdown. They can accumulate in the environment and living organisms, raising health and regulatory concerns. They are widely used across industries—including pharmaceuticals, where they appear in fluorinated API...

Artificial Intelligence is no longer a distant promise — it’s already reshaping the Pharma industry in ways few anticipate. In this provocative keynote, Tech Philosopher and AI expert Bruno Fabre will reveal how AI is not evolving in small steps, but disrupting the very foundations of how we research, deve...

The presentation explores the rapidly growing biologics market and addresses poor accessibility challenges through breakthrough solutions, including an ultra-large scale production line, innovative manufacturing processes featuring Epic-CHO® Cell Line and Grand-CHO® Platform, and revolutionary Panflex®-Eng...

All pharmaceutical or medical device companies with products destined for the United States (US) market, operate under strict manufacturing practices to ensure public safety, efficacy, and consistent product quality. The US Food and Drug Administration (FDA) plays a pivotal role in this oversight through t...

Got questions about AI in pharmaceutical manufacturing? This open-format panel is your chance to ask them. From implementation challenges to regulatory concerns and real-world results, our panel of AI experts and industry insiders are ready to answer it all—no jargon, no sales pitches, just honest insights.

The rapid advancement of mRNA therapies, gene editing, and personalized medicine is transforming drug development, yet analytical bottlenecks in nanoparticle characterization slow down progress. This session explores how emerging technologies, AI-driven data processing, and innovative analytical methodolog...

This session explores the evolving dynamics of pharma and biotech through the lens of capital markets. We will examine current sector trends, including share price performance, valuations, loss of exclusivity (LOE), biotech IPO activity, and capital raising. We’ll also discuss recent M&A developments and t...

Life-saving medicines, such as antibiotics, are essential — but so is the way we produce them. In a time of climate crisis, antimicrobial resistance, and global inequality, the pharmaceutical industry must take a leadership role in building a more sustainable and resilient future. Join us for this sessio...

Cytiva helps the biopharma industry reduce Scope 3 emissions with strategies such as embedding ecodesign principles across our product portfolio and advancing process intensification approaches. Through the use of primary emissions data, we empower manufacturers to make smarter, data-driven sustainability ...

As our understanding of the microbiome deepens, a new horizon is opening beyond classic drug-centric approaches. This session explores how integrating microbiome insights can transform drug development and therapeutic strategies, enabling more precise, effective and sustainable healthcare solutions.
...

How can bioprocessing deliver life-changing medicines while protecting the planet? In this session, Thermo Fisher Scientific will showcase practical innovations that cut carbon, conserve resources, and reduce waste—without compromising performance. From zero-waste certified sites and renewable electricity ...

Today, patients in the United States and around the world depend on medicines—and the ingredients used to make those medicines—sourced from and manufactured around the globe. These dependencies create vulnerabilities which can ripple through the supply chain and affect the delivery of effective healthcare ...

The development of antibody-drug conjugates (ADCs) requires robust, multidisciplinary analytical expertise spanning chemistry, protein science and cellular biology. With a global network of state-of-the-art laboratories, we are uniquely positioned to support clients at every stage of ADC development – from...

This session will begin with an introduction highlighting the critical importance of EcoDesign and carbon footprint reduction in the industry. The presentation will outline Sartorius' comprehensive sustainability strategy, including their ambitious 2045 net-zero carbon commitment and provide an overview of...

As the pharmaceutical industry embraces advanced manufacturing, the fusion of 3D printing and mesoporous silica loading presents a transformative opportunity for tackling solubility challenges in drug development. This session, led by experts from Merck KGaA (Darmstadt, Germany) and Aprecia Pharmaceuticals...

Cytiva helps the biopharma industry reduce Scope 3 emissions with strategies such as embedding ecodesign principles across our product portfolio and advancing process intensification approaches. Through the use of primary emissions data, we empower manufacturers to make smarter, data-driven sustainability ...

Rescripting Global Pharma Manufacturing Footprint Quest for onshoring pharma manufacturing – Regional capacity undoing erstwhile global consolidation COVID-19 laid bare vulnerability of global health systems as a result of highly consolidated global supply chain in pharmaceuticals. This stark realizati...

The biotech research and development landscape is rapidly evolving, driven by advances in biology, technology, and data-driven innovation. This session brings together early-stage biotech innovators to explore how startups are transforming drug discovery, diagnostics, and therapeutic development. Panelists...

What opportunities can the new Critical Medicines Act bring to EU manufacturers of Active Pharmaceutical Ingredients and their intermediates and starting materials? How can it help enhance innovation and competitiveness of our industry and what will the global implications be.

Targeted protein degraders (TPDs), including PROTACs and molecular glues, represent a transformative therapeutic approach but face significant challenges in oral delivery due to their size, polarity, and poor solubility. Enhancing bioavailability is therefore critical to unlocking their full clinical poten...

For decades, GELITA has been providing specialized collagen for vaccine stabilization and applications in bioscience. This presentation delves into the production and use of recombinant collagen proteins and peptides, focusing on their role in vaccine stabilization and various biomedical applications. As w...

This session will address one of the pharmaceutical sector's greatest sustainability challenges: tackling Scope 3 emissions, which are the indirect emissions occurring throughout a company's value chain. Since no single company can achieve net-zero targets independently, the panel will explore how cross-in...

This session introduces a powerful software tool that transforms BLEF data into actionable performance models. Learn how automated data processing, simulation, and visualization accelerate development cycles and enhance cross-functional collaboration.

With this year’s motto “More than you think”, Brenntag Pharma wanted to change the perception the pharma and biopharma industry has of Brenntag. Coming from a commodity distributor world but today deep into the business of APIs, excipients, nutritional health, regulated synthesis, and biopharma as well as ...

Pharma 4.0 is here, and it’s redefining what smart, compliant, and efficient drug manufacturing really looks like. This immersive session takes you inside Kindeva’s brand-new Bridgeton aseptic facility to see how technologies like automated fillers, electronic batch records, and VR modeling are transformin...

The CDMO industry is at an inflection point. The explosive demand for GLP-1 therapies is straining manufacturing capacity, forcing rapid investment in specialized capabilities. Geopolitical tensions are disrupting supply chains, making regional diversification and de-risking strategies more critical than e...

In this session, we will address challenges and potential solutions associated with establishing robust and resilient vaccine manufacturing and supply chains in low- and middle-income countries (LMICs). While these regions face significant constraints in manufacturing capabilities and supply chain logistic...

This presentation explores the complexities of labeling in drug-device combination (DDC) products, emphasizing the importance of integrating labeling considerations throughout the design control process. It outlines the unique challenges posed by DDCs, including regulatory ambiguity, process misalignment, ...

With an increasing industry emphasis on complex modalities, sustainable manufacturing and medicine accessibility, the spotlight has been cast on continuous biomanufacturing as a solution. Our MaruX™ technology platform provides a third dimension to our scale-up and scale-out offering that can be leveraged...

European hospitals face mounting pressures from staff shortages and sustainability demands, requiring medical devices that integrate into workflows while reducing environmental impact. In this context, adoption of new technologies depends on alignment with clinical, procurement, and sustainability prioriti...

Overview: EU GMP Annex 1 - Manufacture of Sterile Medicinal Products. Relevance: Emphasis on Contamination Control Strategy (CCS) aligning with efforts to control Nitrosamines, PFAS, and other impurities. Implementation: Risk-based approach, monitoring systems, holistic mitigation strategies.

As environmental and social responsibility gains prominence in EU trade policy, Latin America’s pharmaceutical sector is experiencing significant shifts. This session will offer a market overview of evolving trade patterns, highlighting how new EU requirements—such as Environmental Risk Assessments (ERAs)—...

As global pharmaceutical markets evolve, Lifecycle Management (LCM) is no longer optional, it’s strategic. This session explores how softgel and Zydis® technologies offer a modern platform for revitalizing mature assets, enhancing bioavailability, and improving patient-centricity. Learn how Catalent’s glob...

Single-use bottles continue to play a significant role in biomanufacturing, yet they often fall short in supporting closed, aseptic, and scalable fluid management. This presentation explores how automated single-use bottle filling bridges that gap. By combining process flexibility with cGMP compliance, aut...

This session will explore OXYCAPT Multilayer Plastic Vials, which feature high oxygen and carbon dioxide barrier properties that are 20 times superior to COP materials. These innovative vials prevent CO2 ingress generated from dry ice and help stabilize drug pH levels, while maintaining excellent container...

The development of antibody-drug conjugates (ADCs) requires robust, multidisciplinary analytical expertise spanning chemistry, protein science and cellular biology. With a global network of state-of-the-art laboratories, we are uniquely positioned to support clients at every stage of ADC development – from...

This session explores how digital health tools and regulatory innovation are transforming pharmaceutical packaging—shifting from traditional paper leaflets to electronic product information (ePI). With a strong focus on the European regulatory environment, the panel will discuss how ePI is unlocking smarte...

The pharmaceutical industry is highly committed to advancing sustainability strategies while maintaining the highest standards of product protection, regulatory compliance, and patient safety. Packaging plays an important role in ensuring medicines remain safe, effective, and accessible to patients worldwi...

Explore how predictive modeling can be integrated across the injector development lifecycle—from design and usability testing to regulatory submissions. This session highlights how modeling supports risk reduction, regulatory confidence, and faster market access.

• Status and Accessibility of Biologics: The Biologics Market is Growing Rapidly & Poor Accessibility of Biologics, Challenges and Solutions • Pathway to $10/g Biologics Production: · Breakthrough Technology: Ultra-large scale Production Line, Innovative Manufacturing Processes: Epic-CHO@ Cell Line ...

Single-use bottles continue to play a significant role in biomanufacturing, yet they often fall short in supporting closed, aseptic, and scalable fluid management. This presentation explores how automated single-use bottle filling bridges that gap. By combining process flexibility with cGMP compliance, aut...

Adopting AI in a CDMO environment is not just a technological decision; it’s a scientific, engineering, and regulatory challenge. In this session, we’ll demystify what AI truly means for pharmaceutical manufacturing and uncover why one-size-fits-all models fall short. You’ll learn why each product and equi...

The rise of pharma has coincided with the rise in globalization. Over the last few years, massive blows have been inflicted on globalization, i.e., the COVID pandemic, geopolitical realignments and now tariffs (and potentially trade war). As the most socialized healthcare continent, all major stakeholders ...

Pharmaceutical development is increasingly shaped by two converging challenges: the technical complexity of formulating emerging molecules and the external pressures of volatile global supply chains. Bioavailability constraints and stability continue to limit progress for small molecules and peptides, whil...

As biologics pipelines expand and complexity rises, the need for smarter, faster innovation has never been greater. AI is poised to transform biologics R&D—not just by accelerating discovery, but by reimagining how we harness data to drive breakthroughs.
This session explores the bigger picture: wha...

The pharmaceutical industry is evolving rapidly, driven by emerging markets, innovative trends, and the growing importance of Contract Development and Manufacturing Organizations (CDMOs). This session will explore how these factors are reshaping the global pharmaceutical landscape, offering new opportuniti...

There are many factors to consider when selecting a chromatography resin for use in a biopharmaceutical purification process. No longer does a singular affinity solution address the needs of increasing molecular complexities, cost and time pressures, as well as operating sustainably. Building on the succes...

The customization of single-use systems and cell culture media (CCM) presents significant opportunities for improving pharmaceutical manufacturing efficiencies, including reduced time, enhanced quality, and optimized resource utilization. However, the qualification of these custom products poses challenges...

Antibody-drug conjugates (ADCs) are transforming targeted therapy, offering greater precision and effectiveness in treating complex diseases. As the field evolves, innovations in linker technology, payload selection, and antibody engineering are driving the next generation of ADCs. However, challenges in s...

The control of nitrosamines and nitrites in pharmaceuticals remains a critical challenge for MAHs, API manufacturers, and regulatory bodies worldwide. Recent updates from EMA and FDA guidance have expanded the scope from small nitrosamines to nitrosamine drug substance-related impurities (NDSRIs), imposing...

In the dynamic landscape of the pharmaceutical industry, local market executives often find themselves at the crossroads of adhering to global directives while addressing unique regional challenges. This session delves into actionable strategies that empower local leaders to craft and implement effective m...

This session will explore how AI is revolutionizing launch excellence in the pharmaceutical industry by driving efficiency, innovation, and impact across the entire value chain. Participants will discover the transformative role of AI in enabling dynamic market segmentation, personalized healthcare profess...

Accelerated timelines are no longer the exception—they’re becoming the norm across the pharmaceutical industry. From oncology to rare diseases, an increasing number of molecules are receiving conditional or expedited approvals, often at earlier stages of development. This trend is reshaping expectations no...

Ensuring the sustained availability of excipients is becoming increasingly complex due to evolving regulations, supply chain vulnerabilities, and the pressing demand for sustainable solutions. This panel will explore critical challenges and opportunities for securing the long-term availability of excipient...

As the pharmaceutical landscape evolves, the demand for large-volume subcutaneous (LVSC) injections is rapidly growing—driven by the need for home-based treatments, improved patient comfort, and a shift from intravenous (IV) to subcutaneous (SC) delivery. Longer injection times are now clinically accepted,...

As pharma packaging and drug delivery innovation accelerate, what should industry leaders be watching now? This forward-looking panel brings together experts to discuss the key themes driving momentum toward Pharmapack—from sustainable materials and smart packaging to connected devices and patient-centric ...

The Pharma industry is being hit simultaneously by multiple, highly complex, rapidly changing issues - ranging from next-generation innovation powered by AI through to unstable tariff regimes, pricing negotiations, regional manufacturing risks and supply chain issues, regulatory harmonisation and so on. Ye...

Wearable devices that monitor vital signs, physical activity, and other health metrics are now utilized by approximately one in three individuals for tracking personal health and wellness. Despite their evident advantages, the integration and widespread adoption of connected devices within the healthcare s...

Motivated by new regulations such as the EU Package and Packaging Waste Regulation (PPWR) and PFAS restriction project from the ECHA, the pharmaceutical industry is undergoing a major transformation. Many of these regulations include guidelines and mandates on the design, size, weight, recyclability, and m...

How can streamlined regulation unlock access to biosimilar medicines and ease pressures on healthcare systems? Regulatory harmonization and efficient development pathways are key to accelerating access to biosimilars. While biologics have transformed care for conditions like cancer and autoimmune diseases...

Ready-to-Use (RTU) containers are emerging as a flexible, efficient, and safe solution for injectable drug products, especially amid complex pipelines and evolving manufacturing needs. However, pharma companies often adopt innovations cautiously, balancing benefits with regulatory and operational concerns....

Continuous manufacturing: A view into the Future of Pharmaceuticals Production Pharmaceutical manufacturing is evolving. As the industry looks for ways to enhance efficiency, improve quality, and strengthen supply chains, continuous manufacturing is emerging as a powerful alternative to traditional batch p...

PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regul...

As the pharmaceutical industry confronts the dual challenge of delivering health solutions while reducing its environmental footprint, the journey to net zero has become both a strategic imperative and a moral responsibility. The challenges that pharma manufacturers, and in particular excipient manufactur...

Semaglutide as Ozempic for Diabetes and Wegovy for weight-loss management, is the world’s second-best selling prescription medicine, with combined sales of $26bn in 2024 and growing annually at a staggering 40%.
In 2026, semaglutide faces loss of exclusivity in key markets, and is set to revolutioni...

The customization of single-use systems and cell culture media (CCM) presents significant opportunities for improving pharmaceutical manufacturing efficiencies, including reduced time, enhanced quality, and optimized resource utilization. However, the qualification of these custom products poses challenges...

Essential medicines are the backbone of global healthcare, yet the economic model sustaining them is under increasing strain. While pharma is often criticised for high prices, the paradox is that many essential drugs—antibiotics among them—are chronically undervalued. The result is fragile supply chains, s...

In an era where high quality, speed and flexibility define success in clinical supply, Catalent is leading the way with transformative packaging innovations. This session will explore how strategic investments in infrastructure and automation are reshaping the packaging landscape to support complex and nic...

This panel will explore how Artificial Intelligence is poised to revolutionise the pharmaceutical industry's sustainability efforts. We'll delve into the tangible benefits AI offers, from ecodesign to reporting, while critically examining the potential drawbacks, ethical dilemmas, and unintended consequenc...

Biologic drug products often require specialized packaging solutions that maintain drug stability and ensure patient safety while dealing with complex molecular structures and unknown sensitivities. In this session you will learn how our Gx Elite Syringe Platform addresses common challenges in this market ...

Nitrosamine impurities—potent, regulatory-scrutinized carcinogens—can arise throughout the drug lifecycle via amine–nitrite reactions during API synthesis, in-process nitrosation, or post-pack degradation. This talk distills the essentials: how and where nitrosamines form; current ICH M7, FDA, and EMA expe...

As the demand for temperature-sensitive pharmaceuticals continues to rise, the need for efficient, compliant, and sustainable cold chain packaging has never been more critical. This discussion will explore how the pharmaceutical industry is navigating the complex landscape of regulatory compliance while al...

As the pharmaceutical industry advances toward more targeted, patient-centric therapies, the need for delivery technologies that bypass the stomach has become critical. Lonza’s Capsugel® Enprotect® capsule represents a breakthrough in enteric technology—offering a bi-layered, ready-to-use solution that pro...

In the pursuit of business excellence, organizations must go beyond efficiency and cost to build operations that are sustainable, resilient, and future-ready. Supply chains are at the heart of this transformation. Join us on how we explore how integrating sustainability into supply chain strategies not onl...

In the pharmaceutical industry, packaging is evolving from a simple protective function to a powerful tool for consumer engagement. Smart, connected packaging technologies are transforming how consumers interact with pharma products, offering personalized experiences, real-time health information, and enha...

ReciBioPharm introduces an advanced process analytical technology (PAT) platform for RNA therapeutics that leverages in-line PAT and machine learning to enable real-time monitoring, control, and optimization. PAT tools provide continuous data throughout the production process—from plasmid linearization to ...

Sustainability is currently one of the key priorities in the pharma industry. Large companies have pledged targets e.g. on carbon emissions, plastic neutrality and other objectives. The cGMP and other regulatory frameworks for pharmaceutical packaging however sets boundaries for the development and product...

As the imperative for the adoption of sustainable practices intensifies, the performance of Lifecycle Assessments (LCA) emerges as a pivotal and strategic imperative within the pharmaceutical industry. This presentation seeks to provide a nuanced and comprehensive exploration of the dynamic domain of autom...

In today's fast-paced market, with shorter time-to-market, rapidly evolving product life cycles, and growing SKU portfolios, brand owners are under increasing pressure. To stay competitive, they’re focusing more on what they do best—building their brands—while outsourcing production, packing, and distribut...

In this session, Aaron Dely, Vice President of R&D at PLD Pharma Services, explores the opportunities and challenges of developing over-the-counter (OTC) and Rx gummies. Dely explains why consumer demand for gummies—driven by improved compliance—is fueling rapid growth and premium pricing in this dosage fo...

This presentation introduces a new strategic collaboration between Indena, an Italian global leader in the development and production of high-quality active pharmaceutical ingredients (APIs) and highly potent APIs (HPAPIs), and TCG GreenChem, an innovative science-driven CDMO based in Princeton, USA. The...

Disruptive Organ-on-Chip Models for Predictive Drug Permeation, Toxicity, and Efficacy Testing.
Discover how next-generation gut-on-chip and skin-on-chip models are reshaping preclinical research. Using the patented MIVO® millifluidic platform, we’ve developed dynamic human tissue systems that accurat...

Enzyme engineering has become a critical enabler of sustainable and efficient processes in the pharmaceutical, chemical, and food industries. However, conventional approaches such as directed evolution or structure-based mutagenesis remain resource-intensive and are often limited by the availability of str...

Global pharmaceutical manufacturing is being redefined by a new era of trade friction, industrial policy, and strategic decoupling. As governments rethink supply chain security and impose new tariffs and incentives, capital is following a different path—away from traditional hubs and toward regionalized, p...

The pharmaceutical sector is redefining what it means to deliver medicines responsibly. Supply chains must become smarter, greener, and faster: using technology and innovation to improve resilience while reducing environmental impact. At CPHI Frankfurt, Magrietha Mallinson will discuss the future of health...

The pharmaceutical industry is pursuing sustainability and carbon neutrality with ambitious goals. Supported by groups like the Green Chemistry Roundtable (ACS), innovators and CDMOs are exploring technologies such as continuous flow, enzymatic reactions, and photochemistry. However, modifying commercial p...

In an era where patient outcomes and satisfaction are paramount, placing the customer at the heart of our strategy and operations is not just beneficial but essential. Understanding Customer Centricity: Customer centricity means prioritizing the needs and experiences of our customers—patients, healthcare...

Pharma's Global Economic Outlook: Balancing Regional Challenges with International Opportunities

The biopharma industry stands at a pivotal moment, facing converging pressures from scientific breakthroughs, regulatory transformation, and shifting economic realities. Traditional innovation models are being reshaped by AI-driven discovery, platform technologies, and health ecosystem integration. In Euro...

The biotech industry faces rapid transformation driven by technological innovation, global market shifts, and healthcare cost pressures, creating critical demand for cost-efficient, scalable biologics manufacturing. Enzene's response is EnzeneX™ 2.0, the next evolution of their Fully-Connected Continuous M...

In today's volatile global environment, maintaining sustainability commitments is not just an ethical choice—it's a strategic necessity for pharmaceutical sector resilience. Rather than viewing sustainability as a secondary initiative, successful organizations recognize it as a cornerstone of trust, compet...

As the EU raises its environmental and social standards in the pharmaceutical sector, Latin American supply chains are feeling the ripple effects. Requirements such as mandatory Environmental Risk Assessments (ERAs) for medicinal products are increasingly influencing how LATAM companies operate—especially ...

Navigating the evolving terrain of biologics from development through commercialization requires a resilient and dependable supply chain. Dual sourcing, which involves procuring essential materials from two distinct suppliers, has emerged as a pivotal strategy to help mitigate risks and enhance supply chai...

With an increasing industry emphasis on complex modalities, sustainable manufacturing and medicine accessibility, the spotlight has been cast on continuous biomanufacturing as a solution. Our MaruX™ technology platform provides a third dimension to our scale-up and scale-out offering that can be leveraged...

This panel will explore the evolving landscape of bio-manufacturing, focusing on the latest technological advancements, process intensification, and the growing sustainability focus. Our experts will discuss how these trends are shaping the future of biologics manufacturing and the challenges companies fac...

As the pace of drug development accelerates, choosing the right early-phase partner is more critical than ever. Lonza is investing in the future of early development through a significant expansion at our Visp site, purpose-built to support fast, flexible, and integrated early-phase programs. In this pre...

The pathway to get to a customized syringe is full of unexpected problems. A holistic and multidisciplinary approach is necessary in order to prevent setbacks and to solve them when they occur. The purpose of this session is to give you some advise and tips in order to arrive to the production of a new cu...

This session will examine how companies can move beyond reactive compliance with CSRD and CSDDD regulations to create meaningful sustainability integration. As these frameworks take hold, the real challenge lies not just in meeting requirements but in embedding sustainability into strategy, governance, and...